Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.
Tornoe has more than 20 years of healthcare industry experience. He previously worked for Pfizer, Wyeth and Bristol-Myers Squibb, quickly advancing his career in a number of senior management positions that dramatically expanded revenues.
"Eric has a great track record in leading and directing teams to exceed corporate business and revenue objectives. He will play an instrumental role in the ongoing success of the company and its continued focus on personalized medicine,” said Scott Glenn, board chairman and CEO.